Pulmonary Hypertension Associated with Left Heart Disease: Clinical Presentations, Implications for the RV and Treatment Target
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Release Date: 02/25/2025
Evolut Low-Risk Trial: 5-year Data Outcomes
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Transcatheter aortic valve replacement (TAVR) has emerged as the preferred treatment for aortic stenosis. However, there is a lack of long-term outcome data for low-risk patients. The 5-year results from the Evolut Low-Risk randomized trial address this gap, offering compelling evidence with no significant negative signals regarding TAVR's clinical outcomes and valve performance. In this episode, Drs. Richard A. Chazal and Michael J. Reardon delve into the 5-year results from the Evolut Low-Risk randomized trial, offering valuable insights about the future of TAVR and its impact on...
info_outline
FRESH-UP Study: Liberal Fluid Intake Versus Fluid Restriction in Chronic Heart Failure
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Fluid restriction is often recommended for heart failure (HF) patients to prevent congestion, but its benefits and safety are unclear. The FRESH-UP study is the first to show that strict fluid restriction does not improve health status for chronic, symptomatic HF patients and may increase thirst distress without reducing mortality, hospitalization, acute kidney injury, or medication needs. In this interview, Roland RJ van Kimmenade, MD and Alison L. Bailey, MD, FACC discuss the impacts of the FRESH-UP study and how liberal fluid intake is safe for chronic HF patients, even enhancing...
info_outline
Chronic Thromboembolic Pulmonary Hypertension (CTEPH): Procedures or Pills?
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Chronic thromboembolic pulmonary hypertension (CTEPH) is a rare and potentially fatal form of elevated blood pressure in the lungs. CTEPH treatment overall is a very complex clinical assessment and medical decision. Treatment options may include pulmonary thromboendarterectomy (PTE) surgery, balloon pulmonary angioplasty (BPA), or medical therapy. In this interview, Drs. Shashank Sinha and Anjali Vaidya discuss how to approach the treatment decision for CTEPH once a diagnosis has been made. Podcasts |
info_outline
A Look at The 2024 AHA/ACC Perioperative Guideline s
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
The 2024 American Heart Association/American College of Cardiology (AHA/ACC)/multisociety guideline for perioperative cardiovascular (CV) management for noncardiac surgery, released in September 2024, marks the fourth comprehensive revision of the perioperative guideline since its inception in 1996. This latest update reflects the most current, evidence-based recommendations, shaped by expert clinical insight, to guide the management of patients with CV conditions undergoing noncardiac surgery. In this interview, Drs. Andrew Kates and Annemarie Thompson discuss the key updates...
info_outline
The Evolving Therapeutic Landscape in Obesity and the Effect on CV Outcomes
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
In this interview, Drs. Richard Chazal and Mikhail Kosiborod explore the rapidly evolving therapeutic landscape of obesity, with a particular focus on the cardiovascular benefits of emerging treatments. They delve into the impact of sodium-glucose co-transporter-2 (SGLT-2) inhibitors and glucagon-like peptide-1 (GLP-1) receptor agonists in enhancing cardiovascular outcomes and improving survival across diverse clinical settings. Their discussion highlights the latest advancements in these therapies, shedding light on their role in reshaping the management of cardiometabolic diseases. ...
info_outline
Getting the Most Out of ChatGPT and Other Large Language Models in Cardiology
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Drafting messages, summarizing charts, managing appointments, and assessing eligibility are all tasks that large language models can streamline. However, integrating them safely and effectively—whether in small practices or large healthcare institutions—poses unique challenges. In this interview, Drs. Dipti Itchhaporia and Marly van Assen explore key strategies and safeguards designed to reduce errors and enhance reliability in high-stakes environments like healthcare. Podcasts | |
info_outline
How Low and How Fast Should We Go with LDL Cholesterol?
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
A personalized approach to lowering cholesterol is crucial in preventing heart attacks, as the optimal level, speed, and duration of low-density lipoprotein (LDL) reduction can vary from person to person. Both physicians and patients must carefully assess and monitor these factors to achieve the best cardiovascular outcomes. In this interview, Drs. Douglas Weaver and Kausik Ray delve into the importance of individualized cholesterol management. They discuss the latest research, the benefits of aggressive LDL reduction, and how tailoring treatment plans can help optimize heart health...
info_outline
Incidental Coronary Artery Calcium: Opportunistic Screening of Prior Non-gated Chest CTs To Improve Statin Rates
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Notifying patients and their clinicians about incidental coronary calcium findings can encourage shared decision-making on preventive therapies and significantly boost statin use among high-risk individuals. Each year, tens of millions of chest computed tomography (CT) scans are performed, yet valuable data on coronary calcium often remain unused — an untapped opportunity to enhance cardiovascular prevention. In this interview, Drs. Glenn Hirsch and Alexander Sandhu discuss how screening previously acquired non-gated chest CTs can help improve statin prescription rates and optimize...
info_outline
Pulmonary Hypertension Associated with Left Heart Disease: Clinical Presentations, Implications for the RV and Treatment Target
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Pulmonary hypertension (PH) is most commonly linked to left heart disease (LHD). The 7th World Symposium on Pulmonary Hypertension PH-LHD task force reviewed newly reported randomized clinical trial results and explored novel strategies to enhance patient outcomes. Their findings uncovered key data essential for improving clinical care. In this interview, Drs. William Boden and Bradley Maron discuss the latest advancements in managing pulmonary hypertension caused by left heart disease. Podcasts |
info_outline
Cardiovascular Health, CKM Syndrome and CVD Risk: Putting It All Together
ACCEL Lite: Featured ACCEL Interviews on Exciting CV Research
Three complementary constructs ̶ cardiovascular health, cardiovascular-kidney-metabolic (CKM) syndrome, and cardiovascular disease (CVD) risk assessment ̶ exist to aid physicians in understanding where a patient is in the journey from health to disease and assist with clinical decision-making for preventive interventions across the life course. In this interview, Drs. Clyde Yancy and Donald Lloyd-Jones review the origins, objectives, and application of these cardiovascular constructs in practice. SUGGESTED MATERIALS: ...
info_outlinePulmonary hypertension (PH) is most commonly linked to left heart disease (LHD). The 7th World Symposium on Pulmonary Hypertension PH-LHD task force reviewed newly reported randomized clinical trial results and explored novel strategies to enhance patient outcomes. Their findings uncovered key data essential for improving clinical care.
In this interview, Drs. William Boden and Bradley Maron discuss the latest advancements in managing pulmonary hypertension caused by left heart disease.
Subscribe on Apple Podcasts | Subscribe to ACCEL